DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Methotrexate - 1 cisplatin - 1 China's - 1 Senators Gary Peters - 1 Debbie Stabenow - 1 Fresenius Kabi - 1
Top related locs:
United States U.S India Hainan Haikou Hainan Province China Toronto
Top related orgs:
Drug Administration - 2 FDA - 2 . Food - 1 National Cancer Institute - 1 Pharmaceutical - 1 U.S - 1 Senators - 1 Intas Pharmaceuticals - 1

Search resuls for: "Qilu Pharmaceutical"


2 mentions found


☆ U.S. seeks new suppliers of highly used cancer drug methotrexate in short supply
  + stars: | 2023-06-09 | by ( ) www.cnbc.com   time to read: +2 min
The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to shore up two other scarce chemotherapy medicines. An FDA spokesperson told Reuters the agency is looking for temporary importation options for the drug, which has been in shortage since March. Methotrexate is an injected drug used to treat a wide variety of cancers ranging from acute lymphoblastic leukemia in children, breast cancer, lung cancer, bone cancers and certain types of head and neck cancers, according to the National Cancer Institute. Last week, the FDA said it was looking for additional temporary suppliers for two other cancer chemotherapies, cisplatin and carboplatin. According to the American Society of Health-System Pharmacists, suppliers with methotrexate injections in shortage or on back order include Accord Healthcare, Fresenius Kabi, Pfizer , Teva and Hikma Pharmaceuticals .
Persons: Methotrexate, cisplatin, China's, Senators Gary Peters, Debbie Stabenow, Fresenius Kabi Organizations: . Food, Drug Administration, FDA, Reuters, National Cancer Institute, Pharmaceutical, U.S, Senators, Intas Pharmaceuticals, Healthcare, American Society of Health, System Pharmacists, Accord Healthcare, Pfizer, Teva, Hikma Pharmaceuticals Locations: United States, India, U.S
☆ FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage
  + stars: | 2023-06-02 | by ( Spencer Kimball | ) www.cnbc.com   time to read: +1 min
The Food and Drug Administration has authorized the temporary importation of an unapproved chemotherapy drug from China in an effort to ease an acute shortage of cancer drugs in the United States, according to an update posted to the agency's website on Friday. The FDA told CNBC this week that the agency was considering imports of unapproved chemotherapy drugs. An FDA spokesperson said the agency assesses the quality of unapproved drug imports to make sure they are safe for U.S. patients. Doctors say some cancer patients could die if the national shortage drugs like cisplatin is not resolved soon. At least 13 other cancer drugs are in short supply across the U.S.
Organizations: Qilu Pharmaceutical, Co, Drug Administration, U.S . Health, FDA, CNBC Locations: Hainan, Haikou, Hainan Province, China, United States, U.S, Toronto, Jinan, Shandong
0 next >>
Total: 2